|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Estimating the world cancer burden: Globocan 2000. Int J Cancer.
94:153–156. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
World Health Organization (WHO): The top
10 causes of death. July. 2013, Available at: http://who.int/mediacentre/factsheets/fs310/en/urisimplewho.int/mediacentre/factsheets/fs310/en/.
(Last accessed: October 2013).
|
|
4
|
Mostafa AA and Morris DG: Immunotherapy
for lung cancer: Has it finally arrived? Front Oncol. 4:2882014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Manser R, Lethaby A, Irving LB, Stone C,
Byrnes G, Abramson MJ and Campbell D: Screening for lung cancer.
Cochrane Database Syst Rev. 6:CD0019912013.PubMed/NCBI
|
|
6
|
Patz EF Jr, Goodman PC and Bepler G:
Screening for lung cancer. N Engl J Med. 343:1627–1633. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Risch A and Plass C: Lung cancer
epigenetics and genetics. Int J Cancer. 123:1–7. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Langevin SM, Kratzke RA and Kelsey KT:
Epigenetics of lung cancer. Transl Res. 165:74–90. 2015. View Article : Google Scholar
|
|
9
|
Berry WL, Shin S, Lightfoot SA and
Janknecht R: Oncogenic features of the JMJD2A histone demethylase
in breast cancer. Int J Oncol. 41:1701–1706. 2012.PubMed/NCBI
|
|
10
|
Berry WL and Janknecht R: KDM4/JMJD2
histone demethylases: Epigenetic regulators in cancer cells. Cancer
Res. 73:2936–2942. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hu CE, Liu YC, Zhang HD and Huang GJ:
JMJD2A predicts prognosis and regulates cell growth in human
gastric cancer. Biochem Biophys Res Commun. 449:1–7. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kauffman EC, Robinson BD, Downes MJ,
Powell LG, Lee MM, Scherr DS, Gudas LJ and Mongan NP: Role of
androgen receptor and associated lysine-demethylase coregulators,
LSD1 and JMJD2A, in localized and advanced human bladder cancer.
Mol Carcinog. 50:931–944. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kogure M, Takawa M, Cho HS, Toyokawa G,
Hayashi K, Tsunoda T, Kobayashi T, Daigo Y, Sugiyama M, Atomi Y, et
al: Deregulation of the histone demethylase JMJD2A is involved in
human carcinogenesis through regulation of the G(1)/S transition.
Cancer Lett. 336:76–84. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mallette FA and Richard S: JMJD2A promotes
cellular transformation by blocking cellular senescence through
transcriptional repression of the tumor suppressor CHD5. Cell Rep.
2:1233–1243. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu W, Jiang K, Shen M, Qian Y and Peng Y:
SIRT2 suppresses non-small cell lung cancer growth by targeting
JMJD2A. Biol Chem. 396:929–936. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Das A, Chai JC, Jung KH, Das ND, Kang SC,
Lee YS, Seo H and Chai YG: JMJD2A attenuation affects cell cycle
and tumourigenic inflammatory gene regulation in lipopolysaccharide
stimulated neuroectodermal stem cells. Exp Cell Res. 328:361–378.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bueno MJ, Pérez de Castro I and Malumbres
M: Control of cell proliferation pathways by microRNAs. Cell Cycle.
7:3143–3148. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Conrad R, Barrier M and Ford LP: Role of
miRNA and miRNA processing factors in development and disease.
Birth Defects Res C Embryo Today. 78:107–117. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schoolmeesters A, Eklund T, Leake D,
Vermeulen A, Smith Q, Force Aldred S and Fedorov Y: Functional
profiling reveals critical role for miRNA in differentiation of
human mesenchymal stem cells. PLoS One. 4:e56052009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu Q, Jin H, Yang Z, Luo G, Lu Y, Li K,
Ren G, Su T, Pan Y, Feng B, et al: miR-150 promotes gastric cancer
proliferation by negatively regulating the pro-apoptotic gene EGR2.
Biochem Biophys Res Commun. 392:340–345. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Waltering KK, Porkka KP, Jalava SE,
Urbanucci A, Kohonen PJ, Latonen LM, Kallioniemi OP, Jenster G and
Visakorpi T: Androgen regulation of micro-RNAs in prostate cancer.
Prostate. 71:604–614. 2011. View Article : Google Scholar
|
|
22
|
Zhang N, Wei X and Xu L: miR-150 promotes
the proliferation of lung cancer cells by targeting P53. FEBS Lett.
587:2346–2351. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cao M, Hou D, Liang H, Gong F, Wang Y, Yan
X, Jiang X, Wang C, Zhang J, Zen K, et al: miR-150 promotes the
proliferation and migration of lung cancer cells by targeting SRC
kinase signalling inhibitor 1. Eur J Cancer. 50:1013–1024. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dong S, Cheng Y, Yang J, Li J, Liu X, Wang
X, Wang D, Krall TJ, Delphin ES and Zhang C: MicroRNA expression
signature and the role of microRNA-21 in the early phase of acute
myocardial infarction. J Biol Chem. 284:29514–29525. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang LQ, Zhang Y, Yan H, Liu KJ and Zhang
S: MicroRNA-373 functions as an oncogene and targets YOD1 gene in
cervical cancer. Biochem Biophys Res Commun. 459:515–520. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar
|
|
27
|
Pham H, Rodriguez CE, Donald GW, Hertzer
KM, Jung XS, Chang HH, Moro A, Reber HA, Hines OJ and Eibl G:
miR-143 decreases COX-2 mRNA stability and expression in pancreatic
cancer cells. Biochem Biophys Res Commun. 439:6–11. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang X, Dong Y, Ti H, Zhao J, Wang Y, Li
T and Zhang B: Down-regulation of miR-145 and miR-143 might be
associated with DNA methyltransferase 3B overexpression and worse
prognosis in endometrioid carcinomas. Hum Pathol. 44:2571–2580.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Puerta-Gil P, García-Baquero R, Jia AY,
Ocaña S, Alvarez-Múgica M, Alvarez-Ossorio JL, Cordon-Cardo C, Cava
F and Sánchez-Carbayo M: miR-143, miR-222, and miR-452 are useful
as tumor stratification and noninvasive diagnostic biomarkers for
bladder cancer. Am J Pathol. 180:1808–1815. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang M, Yang W, Li M and Li Y: Low
expression of miR-150 in pediatric intestinal Burkitt lymphoma. Exp
Mol Pathol. 96:261–266. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fourie NH, Peace RM, Abey SK, Sherwin LB,
Rahim-Williams B, Smyser PA, Wiley JW and Henderson WA: Elevated
circulating miR-150 and miR-342-3p in patients with irritable bowel
syndrome. Exp Mol Pathol. 96:422–425. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen RF, Yang KD, Lee IK, Liu JW, Huang
CH, Lin CY, Chen YH, Chen CL and Wang L: Augmented miR-150
expression associated with depressed SOCS1 expression involved in
dengue haemorrhagic fever. J Infect. 69:366–374. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jiang X, Huang H, Li Z, Li Y, Wang X,
Gurbuxani S, Chen P, He C, You D, Zhang S, et al: Blockade of
miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for
MLL-associated leukemia. Cancer Cell. 22:524–535. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Honda N, Jinnin M, Kira-Etoh T, Makino K,
Kajihara I, Makino T, Fukushima S, Inoue Y, Okamoto Y, Hasegawa M,
et al: miR-150 down-regulation contributes to the constitutive type
I collagen overexpression in scleroderma dermal fibroblasts via the
induction of integrin β3. Am J Pathol. 182:206–216. 2013.
View Article : Google Scholar
|
